Euro Commission allow genetic engineering on humans for business purposes.
First medicine for weight loss.
European officials have approved a first commercial use of gene therapy in humans - a method of treatment which should be repaired "bug in the human genetic code."
The first controversial drug, changing genes for weight loss.
European Commission has authorized a small Dutch company that sells drugs for rare disease from which one can not get rid of excess fat.
So far in the U.S. and Europe for the treatment of this method is still allowed only in research laboratories as the first country to allow this type of gene therapy is China.
Dutch drug called Glybera is a virus that infects muscle cells with working copies of a damaged gene.